Eli Lilly gets FDA approval for new obesity drug By: MarketWatch November 08, 2023 at 13:22 PM EST Zepbound helped patients lose up to 48 pounds on average in clinical trials. Read More >> Related Stocks: Eli Lilly Novo Nordisk A/S ADR